Response to comments on: Long-term results of a single injection of intravitreal dexamethasone as initial therapy in diabetic macular edema.
作者信息
Mahapatra Santosh Kumar, Kumari Swati
机构信息
Department of Vitreoretina, JPM Rotary Club of Cuttack Eye Hospital and Research Institute, CDA, Cuttack, Odisha, India.
出版信息
Indian J Ophthalmol. 2021 Jan;69(1):189-190. doi: 10.4103/ijo.IJO_2929_20.
Abstract
摘要
相似文献
1
Response to comments on: Long-term results of a single injection of intravitreal dexamethasone as initial therapy in diabetic macular edema.对关于“单次玻璃体内注射地塞米松作为糖尿病性黄斑水肿初始治疗的长期结果”评论的回复
Indian J Ophthalmol. 2021 Jan;69(1):189-190. doi: 10.4103/ijo.IJO_2929_20.
2
Response to comments on: Long-term results of a single injection of intravitreal dexamethasone as initial therapy in diabetic macular edema.对关于“单次玻璃体内注射地塞米松作为糖尿病性黄斑水肿初始治疗的长期结果”评论的回应
Indian J Ophthalmol. 2021 Jan;69(1):187-188. doi: 10.4103/ijo.IJO_1136_20.
3
Comments on: Long-term results of a single injection of intravitreal dexamethasone as initial therapy in diabetic macular edema.关于：单次玻璃体内注射地塞米松作为糖尿病性黄斑水肿初始治疗的长期结果的评论
Indian J Ophthalmol. 2021 Jan;69(1):188-189. doi: 10.4103/ijo.IJO_2562_20.
4
Comments on: Long-term results of a single injection of intravitreal dexamethasone as initial therapy in diabetic macular edema.关于：单次玻璃体内注射地塞米松作为糖尿病性黄斑水肿初始治疗的长期结果的评论
Indian J Ophthalmol. 2021 Jan;69(1):186-187. doi: 10.4103/ijo.IJO_596_20.
5
Long-term results of a single injection of intravitreal dexamethasone as initial therapy in diabetic macular edema.玻璃体内单次注射地塞米松作为糖尿病性黄斑水肿初始治疗的长期结果。
Indian J Ophthalmol. 2020 Mar;68(3):490-493. doi: 10.4103/ijo.IJO_620_19.
6
OZURDEX® (Dexamethasone Intravitreal Implant) 0.7 mg as Initial Therapy in Pseudophakic Patients With Diabetic Macular Edema, Macular Edema Following Retinal Vein Occlusion, and Noninfectious Posterior Segment Uveitis: A Case-Based Discussion.Ozurdex®（地塞米松玻璃体内植入剂）0.7毫克作为初始治疗用于假晶状体糖尿病性黄斑水肿、视网膜静脉阻塞后黄斑水肿及非感染性后段葡萄膜炎患者：基于病例的讨论
Retina. 2019 Jun;39 Suppl 1:S1-S28. doi: 10.1097/01.iae.0000574292.81105.b2.
7
Comment on: Effect of sustained-release long-acting intravitreal dexamethasone implant in patients of non-proliferative diabetic retinopathy undergoing phacoemulsification: A randomized controlled trial.评论：长效玻璃体内注射地塞米松植入物对接受白内障超声乳化手术的非增殖性糖尿病视网膜病变患者的影响：一项随机对照试验。
Indian J Ophthalmol. 2022 Feb;70(2):697-698. doi: 10.4103/ijo.IJO_2952_21.
8
Clinical Decision-Making when Treating Diabetic Macular Edema Patients with Dexamethasone Intravitreal Implants.使用地塞米松玻璃体内植入物治疗糖尿病性黄斑水肿患者时的临床决策
Ophthalmologica. 2018;240(2):61-72. doi: 10.1159/000486800. Epub 2018 Apr 4.
9
Response to comment on: Intravitreal anti-vascular endothelial growth factor with and without topical non-steroidal anti-inflammatory in centre-involving diabetic macular edema.对关于“在累及黄斑中心的糖尿病性黄斑水肿中玻璃体内注射抗血管内皮生长因子联合或不联合局部非甾体抗炎药”评论的回复
Indian J Ophthalmol. 2022 Jun;70(6):2209. doi: 10.4103/ijo.IJO_750_22.
10
Comment on: Intravitreal anti-vascular endothelial growth factor with and without topical non-steroidal anti-inflammatory in centre-involving diabetic macular edema.关于“在累及黄斑中心的糖尿病性黄斑水肿中玻璃体内注射抗血管内皮生长因子联合或不联合局部非甾体抗炎药”的评论
Indian J Ophthalmol. 2022 Jun;70(6):2208. doi: 10.4103/ijo.IJO_455_22.
本文引用的文献
1
Comments on: Long-term results of a single injection of intravitreal dexamethasone as initial therapy in diabetic macular edema.关于：单次玻璃体内注射地塞米松作为糖尿病性黄斑水肿初始治疗的长期结果的评论
Indian J Ophthalmol. 2021 Jan;69(1):188-189. doi: 10.4103/ijo.IJO_2562_20.
2
Long-term results of a single injection of intravitreal dexamethasone as initial therapy in diabetic macular edema.玻璃体内单次注射地塞米松作为糖尿病性黄斑水肿初始治疗的长期结果。
Indian J Ophthalmol. 2020 Mar;68(3):490-493. doi: 10.4103/ijo.IJO_620_19.
3
DEXAMETHASONE IMPLANT FOR DIABETIC MACULAR EDEMA IN NAIVE COMPARED WITH REFRACTORY EYES: The International Retina Group Real-Life 24-Month Multicenter Study. The IRGREL-DEX Study.地塞米松植入物治疗初治与难治性糖尿病性黄斑水肿眼的比较：国际视网膜专家组真实世界 24 个月多中心研究。IRGREL-DEX 研究。
Retina. 2019 Jan;39(1):44-51. doi: 10.1097/IAE.0000000000002196.
4
Morphology and Function over a One-Year Follow Up Period after Intravitreal Dexamethasone Implant (Ozurdex) in Patients with Diabetic Macular Edema.糖尿病性黄斑水肿患者玻璃体内植入地塞米松（Ozurdex）后一年随访期的形态学与功能
PLoS One. 2015 Dec 31;10(12):e0145663. doi: 10.1371/journal.pone.0145663. eCollection 2015.
5
Treatment of anti-vascular endothelial growth factor-resistant diabetic macular edema with dexamethasone intravitreal implant.玻璃体内植入地塞米松治疗抗血管内皮生长因子抵抗的糖尿病黄斑水肿。
Retina. 2014 Apr;34(4):719-24. doi: 10.1097/IAE.0b013e3182a48958.
6
Preliminary results of an intravitreal dexamethasone implant (Ozurdex®) in patients with persistent diabetic macular edema.玻璃体内注射地塞米松植入剂（Ozurdex®）治疗持续性糖尿病性黄斑水肿患者的初步结果。
Clin Ophthalmol. 2013;7:1423-8. doi: 10.2147/OPTH.S48364. Epub 2013 Jul 16.
7
Short-term results of intravitreal dexamethasone implant (OZURDEX(®)) in treatment of recalcitrant diabetic macular edema: A case series.玻璃体内注射地塞米松植入物（奥助得（®））治疗顽固性糖尿病性黄斑水肿的短期结果：病例系列
Oman J Ophthalmol. 2012 May;5(2):79-82. doi: 10.4103/0974-620X.99368.
8
Correlation of visual acuity and macular thickness measured by optical coherence tomography in patients with persistent macular edema.光学相干断层扫描测量持续性黄斑水肿患者的视力和黄斑厚度的相关性。
Retina. 2010 Jul-Aug;30(7):1090-4. doi: 10.1097/IAE.0b013e3181dcfaf3.
9
Randomized controlled study of an intravitreous dexamethasone drug delivery system in patients with persistent macular edema.玻璃体内地塞米松药物递送系统治疗持续性黄斑水肿患者的随机对照研究
Arch Ophthalmol. 2007 Mar;125(3):309-17. doi: 10.1001/archopht.125.3.309.
Zotero 插件